Skip to main content
logo
ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,890.00
+85.00 (3.03%)
At close: Sep 4, 2026

ImmuneOncia Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
263,965965,629----
Market Cap Growth
-35.99%-----
Enterprise Value
170,838934,053----
Last Close Price
2890.0012093.37----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-8683.03----
PB Ratio
2.6333.98----
P/TBV Ratio
2.7540.38----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-8399.10----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
00.000.010.010.000.00
Net Debt / Equity Ratio
-0.93-0.82-0.58-0.860.510.71
Net Debt / EBITDA Ratio
3.170.860.972.401.903.86
Net Debt / FCF Ratio
3.491.010.762.951.7420.22
Asset Turnover
-0.000.020.000.180.00
Quick Ratio
20.735.533.007.757.164.80
Current Ratio
22.026.223.067.907.534.84
Return on Equity (ROE)
-39.66%-114.39%-22.97%---
Return on Assets (ROA)
-24.03%-58.99%-26.25%-21.22%-21.71%-18.57%
Return on Capital Employed (ROCE)
-30.00%-96.90%-63.90%-38.80%-47.30%-28.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.10%-2.83%----
FCF Yield
-10.11%-2.39%----
Buyback Yield / Dilution
-21.39%-24.72%-7.35%-0.64%-12.17%-904.47%